Cargando…
MS-Therapie im Alter - Was gilt es zu bedenken?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700109/ http://dx.doi.org/10.1007/s15202-020-2900-6 |
_version_ | 1783616202130587648 |
---|---|
author | Pawlitzki, Marc Meuth, Sven G. |
author_facet | Pawlitzki, Marc Meuth, Sven G. |
author_sort | Pawlitzki, Marc |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7700109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-77001092020-12-01 MS-Therapie im Alter - Was gilt es zu bedenken? Pawlitzki, Marc Meuth, Sven G. DNP Fortbildung Springer Medizin 2020-12-03 2020 /pmc/articles/PMC7700109/ http://dx.doi.org/10.1007/s15202-020-2900-6 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Fortbildung Pawlitzki, Marc Meuth, Sven G. MS-Therapie im Alter - Was gilt es zu bedenken? |
title | MS-Therapie im Alter - Was gilt es zu bedenken? |
title_full | MS-Therapie im Alter - Was gilt es zu bedenken? |
title_fullStr | MS-Therapie im Alter - Was gilt es zu bedenken? |
title_full_unstemmed | MS-Therapie im Alter - Was gilt es zu bedenken? |
title_short | MS-Therapie im Alter - Was gilt es zu bedenken? |
title_sort | ms-therapie im alter - was gilt es zu bedenken? |
topic | Fortbildung |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700109/ http://dx.doi.org/10.1007/s15202-020-2900-6 |
work_keys_str_mv | AT pawlitzkimarc mstherapieimalterwasgilteszubedenken AT meuthsveng mstherapieimalterwasgilteszubedenken |